Blinded trial
- A trial in which the
clinical research
investigator and the patient do not
know which of the discussed treatment options will be administered to that
particular patient. The purpose of a blind trial is to be sure that
expectations do not influence the outcome of the trial. The opposite of a
blind trial is an "open label" study.
Clinical research investigator – This is usually a physician, but
always a specialist trained in the management of clinical research.
Clinical research coordinator - This is a health care professional,
often a nurse, who assists the investigator in managing the trial.
Consent form – Contains all relevant study information explained in
lay terms and documents voluntary participation of
subject.
Presented to and signed by subject.
Informed consent – A discussion required by the FDA to take place
before a
participant
can enroll in a trial. It is an information exchange that includes subject
recruitment materials, verbal instruction, written materials, question and
answer sessions and signature documenting consent with date.
Institutional Review Board (IRB) - The committee which regulates the
way in which Guthrie clinical trial research may be conducted . The IRB
reviews research and
consent
forms to determine if the rights and
welfare of subjects
are protected.
Investigational materials - A drug or device not yet approved by the
FDA.
Open label study - A trial in which the clinical
research investigator
and the patient
know which of the discussed treatment options will be administered to that
particular patient.
Placebo – A drug that will have no effect or medical activity, used
in a blind trial to ensure that expectations of outcome do not influence the
clinical result.
Sponsor – A company, a research entity or individual who wishes to
investigate the effectiveness of a new treatment and provides the funding
required to conduct the investigation.
Subject – A patient or healthy individual who volunteers to
participate in a clinical trial, or who will be participating in a research
study. Also called a participant.